Skip to main content
About Us
Overview
Leadership Team
Board of Directors
Pipeline
Clinical Trials
Our Approach
Investors
Overview
Press Releases
Events & Presentations
Stock Information
Stock Quote
Stock Chart
Historical Stock Quote
SEC Filings
Corporate Governance
Executive Management
Board of Directors
Committee Composition
Investor FAQs
Email Alerts Subscription
Contact Us
Press Releases
About Us
Overview
Leadership Team
Board of Directors
Pipeline
Clinical Trials
Our Approach
Investors
Contact Us
Search Mobile
Overview
Press Releases
Events & Presentations
Stock Information
Stock Quote
Stock Chart
Historical Stock Quote
SEC Filings
Corporate Governance
Executive Management
Board of Directors
Committee Composition
Investor FAQs
Email Alerts Subscription
Contact Us
Normal
Press release year list
2020
2019
2018
2017
2016
2015
2014
2013
2012
October 18, 2016
ADC Therapeutics Announces Closing of $105 Million Private Financing
Download
PDF format download (opens in new window)
April 12, 2016
ADC Therapeutics Doses First Patient in a Phase I Clinical Trial of ADCT-402 for Patients with B-cell lineage Acute Lymphoblastic Leukemia
Download
PDF format download (opens in new window)
March 11, 2016
ADC Therapeutics Doses First Patient in Phase I Trial of ADCT-402 in CD-19 Positive B-cell Non-Hodgkin Lymphomas
Download
PDF format download (opens in new window)
February 09, 2016
ADC Therapeutics Doses First Patient in Phase I Trial of ADCT-301 in Acute Myeloid Leukemia
Download
PDF format download (opens in new window)